Cryptococcal meningitis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000627:therapeutic use; D001773:Blood Cells; D002339:Carotid Arteries / Q000000981:diagnostic imaging; D014695:Cerebral Ventriculography; D002555:Cerebrospinal Fluid / Q000032:analysis; D003453:Cryptococcosis / Q000188:drug therapy; D004569:Electroencephalography; D005260:Female; D006452:Hemoglobinometry; D006801:Humans; D006849:Hydrocephalus / Q000000981:diagnostic imaging; D008111:Liver Function Tests; D008168:Lung / Q000601:surgery; D008297:Male; D008581:Meningitis / Q000150:complications / Q000188:drug therapy; D008875:Middle Aged; D009431:Neural Conduction; D009461:Neurologic Manifestations; D010211:Papilledema / Q000150:complications; D010525:Peripheral Nerves; D011188:Potassium / Q000097:blood; D011312:Pressure; D011379:Prognosis; D013997:Time Factors; D014508:Urea / Q000097:blood; D014786:Vision Disorders / Q000150:complications
D000666:Amphotericin B; D014508:Urea; D011188:Potassium